The apolipoprotein B R3531C mutation. Characteristics of 24 subjects from 9 kindreds, J. Lipid Res, vol.40, pp.318-327, 1999. ,
Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia, European Heart Journal, vol.33, issue.11, pp.1360-1366, 2012. ,
DOI : 10.1093/eurheartj/ehs010
Identifi cation and biochemical analysis of a novel APOB mutation that causes autosomal dominant hypercholesterolemia, 2013. ,
Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolaemia, Human Molecular Genetics, vol.23, issue.7, pp.1817-1828, 2014. ,
DOI : 10.1093/hmg/ddt573
PCSK9: From discovery to therapeutic applications, Archives of Cardiovascular Diseases, vol.107, issue.1, pp.58-66, 2014. ,
DOI : 10.1016/j.acvd.2013.10.007
PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future, European Heart Journal, vol.36, issue.36, pp.2415-2424, 2015. ,
DOI : 10.1093/eurheartj/ehv174
Apolipoprotein E structure: insights into function, Trends in Biochemical Sciences, vol.31, issue.8, pp.445-454, 2006. ,
DOI : 10.1016/j.tibs.2006.06.008
Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review, American Journal of Epidemiology, vol.155, issue.6, pp.487-495, 2002. ,
DOI : 10.1093/aje/155.6.487
Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: Systematic review and meta-analysis of 14 015 stroke cases and pooled analysis of primary biomarker data from up to 60 883 individuals, International Journal of Epidemiology, vol.42, issue.2, pp.475-492, 2013. ,
DOI : 10.1093/ije/dyt034
Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics, The American Journal of Cardiology, vol.72, issue.2, pp.171-176, 1993. ,
DOI : 10.1016/0002-9149(93)90155-6
Familial hypercholesterolemia, Lipids and Vascular Dunitz, pp.65-76, 2000. ,
Diagnosis Scoring for Clinical Identification of Children With Heterozygous Familial Hypercholesterolemia, Journal of Pediatric Gastroenterology and Nutrition, vol.48, issue.4, pp.456-463, 2009. ,
DOI : 10.1097/MPG.0b013e3181810b30
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm, Nature Protocols, vol.4, issue.8, pp.1073-1081, 2009. ,
DOI : 10.1101/gr.772403
A method and server for predicting damaging missense mutations, Nature Methods, vol.7, issue.4, pp.248-249, 2010. ,
DOI : 10.1038/nmeth0410-248
CUPSAT: prediction of protein stability upon point mutations, Nucleic Acids Research, vol.34, issue.Web Server, pp.239-242, 2006. ,
DOI : 10.1093/nar/gkl190
Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions, Proc. Natl. Acad. Sci. USA, pp.14813-14818, 2011. ,
DOI : 10.1007/s10858-011-9526-0
Splicing in action: assessing disease causing sequence changes, Journal of Medical Genetics, vol.42, issue.10, pp.737-748, 2005. ,
DOI : 10.1136/jmg.2004.029538
U1 snRNA mis-binding: a new cause of CMT1B, neurogenetics, vol.111, issue.5, pp.13-19, 2010. ,
DOI : 10.1007/BF00206959
Functional Characterization of Putative Novel Splicing Mutations in the Cardiomyopathy-Causing Genes, DNA and Cell Biology, vol.34, issue.7, pp.489-496, 2015. ,
DOI : 10.1089/dna.2015.2842
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society, European Heart Journal, vol.34, issue.45, pp.3478-3490 ,
DOI : 10.1093/eurheartj/eht273
Genetic heterogeneity of autosomal dominant hypercholesterolemia, Clinical Genetics, vol.6, issue.2, pp.1-13, 2008. ,
DOI : 10.1161/01.ATV.17.4.741
mutations, Journal of Medical Genetics, vol.45, issue.8, pp.537-544, 2014. ,
DOI : 10.1038/ng.2797
p.Leu167del Mutation, Human Mutation, vol.257, issue.2, pp.83-87, 2013. ,
DOI : 10.1007/s11883-001-0061-4
APOE p.Leu167del mutation in familial hypercholesterolemia, Atherosclerosis, vol.231, issue.2, pp.218-222, 2013. ,
DOI : 10.1016/j.atherosclerosis.2013.09.007
Identifi cation, molecular characterization, and cellular studies of an apolipoprotein E mutant (E1) in three unrelated families with hyperlipidemia, J. Clin. Endocrinol. Metab, vol.80, pp.807-813, 1995. ,
Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia, Atherosclerosis, vol.222, issue.2, pp.449-455, 2012. ,
DOI : 10.1016/j.atherosclerosis.2012.03.011
The Type of LDLR Gene Mutation Predicts Cardiovascular Risk in Children with Familial Hypercholesterolemia, The Journal of Pediatrics, vol.155, issue.2, pp.199-204, 2009. ,
DOI : 10.1016/j.jpeds.2009.02.022
Molecular Spectrum of Autosomal Dominant Hypercholesterolemia in France, Human Mutation, vol.31, issue.11, pp.1811-1824, 2010. ,
DOI : 10.1002/humu.21348
URL : https://hal.archives-ouvertes.fr/hal-00573066
Molecular Basis of Autosomal Dominant Hypercholesterolemia: Assessment in a Large Cohort of Hypercholesterolemic Children, Circulation, vol.123, issue.11, pp.1167-1173, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.110.979450
Mutational analysis of a cohort with clinical diagnosis of familial hypercholesterolemia: considerations for genetic diagnosis improvement, Genetics in Medicine, vol.7, issue.4, 2015. ,
DOI : 10.1258/jrsm.97.5.226
Intronic mutations outside of Alu -repeat-rich domains of the LDL receptor gene are a cause of familial hypercholesterolemia, Human Genetics, vol.111, issue.6, pp.501-510, 2002. ,
DOI : 10.1007/s00439-002-0813-4
Lipid Disorders and Mutations in the APOB Gene, Clinical Chemistry, vol.50, issue.10, pp.1725-1732, 2004. ,
DOI : 10.1373/clinchem.2004.038026
The Molecular Mechanism for the Genetic Disorder Familial Defective Apolipoprotein B100, Journal of Biological Chemistry, vol.256, issue.12, pp.9214-9218, 2001. ,
DOI : 10.1172/JCI5549
Independent mutations at codon 37 Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate, Atherosclerosis, vol.182, pp.331-340, 1995. ,
Helix geometry in proteins, Journal of Molecular Biology, vol.201, issue.3, pp.601-619, 1988. ,
DOI : 10.1016/0022-2836(88)90641-9
Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4, Journal of Biological Chemistry, vol.1768, issue.18, pp.12931-12945, 2014. ,
DOI : 10.1073/pnas.95.18.10914
Mutations in STAP1 Are Associated With Autosomal Dominant Hypercholesterolemia, Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia, pp.552-555, 2014. ,
DOI : 10.1161/CIRCRESAHA.115.304660
A fourth locus for autosomal dominant hypercholesterolemia maps at 16q22.1, European Journal of Human Genetics, vol.73, issue.11, pp.1236-1242 ,
DOI : 10.1016/S1388-1981(01)00187-1
URL : https://hal.archives-ouvertes.fr/hal-00549893
Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS, Journal of Lipid Research, vol.40, issue.Supplement, pp.183-188, 2009. ,
DOI : 10.1097/00041433-199906000-00003
Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype???phenotype relationship, and clinical outcome, European Heart Journal, vol.36, issue.9, pp.560-565, 2014. ,
DOI : 10.1093/eurheartj/ehu058
Apolipoprotein E-low density lipoprotein receptor interaction: infl uences of basic residue and amphipathic alpha-helix organization in the ligand, J. Lipid Res, vol.41, pp.1087-1095, 2000. ,
Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site, 1982. ,
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures, Journal of Applied Crystallography, vol.24, issue.5, pp.946-950, 1991. ,
DOI : 10.1107/S0021889891004399
Raster3D: photorealistic molecular graphics www.jlr.org Downloaded from, P055699.DC1 Supplemental Material can be found at, pp.505-524, 1997. ,
DOI : 10.1016/s0076-6879(97)77028-9